Work

Tremelimumab (CP-675,206): a fully human anticytotoxic T lymphocyte-associated antigen 4 monoclonal antibody for treatment of patients with advanced cancers

Year: 2008

Type: article

Source: Expert Opinion on Biological Therapy

DOI: 10.1517/14712598.8.10.1583

Authors: Ahmad A Tarhini, John M Kirkwood

Institutions: University of Pittsburgh, UPMC Health System, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Pfizer

OpenAlex ID: W2030395337

FWCI: 1.393

Cites: 39

Cited by: 44

Related to: 10